Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 81

1.

Transcriptomic profiling of the human brain reveals that altered synaptic gene expression is associated with chronological aging.

Dillman AA, Majounie E, Ding J, Gibbs JR, Hernandez D, Arepalli S, Traynor BJ, Singleton AB, Galter D, Cookson MR.

Sci Rep. 2017 Dec 4;7(1):16890. doi: 10.1038/s41598-017-17322-0.

2.

Genetic Variations and mRNA Expression of NRF2 in Parkinson's Disease.

Ran C, Wirdefeldt K, Brodin L, Ramezani M, Westerlund M, Xiang F, Anvret A, Willows T, Sydow O, Johansson A, Galter D, Svenningsson P, Belin AC.

Parkinsons Dis. 2017;2017:4020198. doi: 10.1155/2017/4020198. Epub 2017 May 2.

3.

Myeloperoxidase-immunoreactive cells are significantly increased in brain areas affected by neurodegeneration in Parkinson's and Alzheimer's disease.

Gellhaar S, Sunnemark D, Eriksson H, Olson L, Galter D.

Cell Tissue Res. 2017 Sep;369(3):445-454. doi: 10.1007/s00441-017-2626-8. Epub 2017 May 2.

4.

Histamine induces KCNQ channel-dependent gamma oscillations in rat hippocampus via activation of the H1 receptor.

Andersson R, Galter D, Papadia D, Fisahn A.

Neuropharmacology. 2017 May 15;118:13-25. doi: 10.1016/j.neuropharm.2017.03.003. Epub 2017 Mar 6.

PMID:
28274820
5.

Development of carvedilol-cyclodextrin inclusion complexes using fluid-bed granulation: a novel solid-state complexation alternative with technological advantages.

Alonso EC, Riccomini K, Silva LA, Galter D, Lima EM, Durig T, Taveira SF, Martins FT, Cunha-Filho MS, Marreto RN.

J Pharm Pharmacol. 2016 Oct;68(10):1299-309. doi: 10.1111/jphp.12601. Epub 2016 Jul 27.

PMID:
27465985
6.

Strong association between glucocerebrosidase mutations and Parkinson's disease in Sweden.

Ran C, Brodin L, Forsgren L, Westerlund M, Ramezani M, Gellhaar S, Xiang F, Fardell C, Nissbrandt H, Söderkvist P, Puschmann A, Ygland E, Olson L, Willows T, Johansson A, Sydow O, Wirdefeldt K, Galter D, Svenningsson P, Belin AC.

Neurobiol Aging. 2016 Sep;45:212.e5-212.e11. doi: 10.1016/j.neurobiolaging.2016.04.022. Epub 2016 May 3.

7.

Altered Expression of Growth Associated Protein-43 and Rho Kinase in Human Patients with Parkinson's Disease.

Saal KA, Galter D, Roeber S, Bähr M, Tönges L, Lingor P.

Brain Pathol. 2017 Jan;27(1):13-25. doi: 10.1111/bpa.12346. Epub 2016 Feb 22.

PMID:
26748453
8.

ADAR2 affects mRNA coding sequence edits with only modest effects on gene expression or splicing in vivo.

Dillman AA, Cookson MR, Galter D.

RNA Biol. 2016;13(1):15-24. doi: 10.1080/15476286.2015.1110675.

9.

Large-scale assessment of polyglutamine repeat expansions in Parkinson disease.

Wang L, Aasly JO, Annesi G, Bardien S, Bozi M, Brice A, Carr J, Chung SJ, Clarke C, Crosiers D, Deutschländer A, Eckstein G, Farrer MJ, Goldwurm S, Garraux G, Hadjigeorgiou GM, Hicks AA, Hattori N, Klein C, Jeon B, Kim YJ, Lesage S, Lin JJ, Lynch T, Lichtner P, Lang AE, Mok V, Jasinska-Myga B, Mellick GD, Morrison KE, Opala G, Pihlstrøm L, Pramstaller PP, Park SS, Quattrone A, Rogaeva E, Ross OA, Stefanis L, Stockton JD, Silburn PA, Theuns J, Tan EK, Tomiyama H, Toft M, Van Broeckhoven C, Uitti RJ, Wirdefeldt K, Wszolek Z, Xiromerisiou G, Yueh KC, Zhao Y, Gasser T, Maraganore DM, Krüger R, Sharma M; GEO-PD Consortium.

Neurology. 2015 Oct 13;85(15):1283-92. doi: 10.1212/WNL.0000000000002016. Epub 2015 Sep 9.

10.

An organic electronic biomimetic neuron enables auto-regulated neuromodulation.

Simon DT, Larsson KC, Nilsson D, Burström G, Galter D, Berggren M, Richter-Dahlfors A.

Biosens Bioelectron. 2015 Sep 15;71:359-364. doi: 10.1016/j.bios.2015.04.058. Epub 2015 Apr 22.

11.

No dopamine cell loss or changes in cytoskeleton function in transgenic mice expressing physiological levels of wild type or G2019S mutant LRRK2 and in human fibroblasts.

Garcia-Miralles M, Coomaraswamy J, Häbig K, Herzig MC, Funk N, Gillardon F, Maisel M, Jucker M, Gasser T, Galter D, Biskup S.

PLoS One. 2015 Apr 1;10(4):e0118947. doi: 10.1371/journal.pone.0118947. eCollection 2015.

12.

Chronic L-DOPA induces hyperactivity, normalization of gait and dyskinetic behavior in MitoPark mice.

Gellhaar S, Marcellino D, Abrams MB, Galter D.

Genes Brain Behav. 2015 Mar;14(3):260-70. doi: 10.1111/gbb.12210. Erratum in: Genes Brain Behav. 2015 Jun;14(5):442.

13.

Conditional expression of Parkinson's disease-related R1441C LRRK2 in midbrain dopaminergic neurons of mice causes nuclear abnormalities without neurodegeneration.

Tsika E, Kannan M, Foo CS, Dikeman D, Glauser L, Gellhaar S, Galter D, Knott GW, Dawson TM, Dawson VL, Moore DJ.

Neurobiol Dis. 2014 Nov;71:345-58. doi: 10.1016/j.nbd.2014.08.027. Epub 2014 Aug 29.

14.

Behavioral deficits and striatal DA signaling in LRRK2 p.G2019S transgenic rats: a multimodal investigation including PET neuroimaging.

Walker MD, Volta M, Cataldi S, Dinelle K, Beccano-Kelly D, Munsie L, Kornelsen R, Mah C, Chou P, Co K, Khinda J, Mroczek M, Bergeron S, Yu K, Cao LP, Funk N, Ott T, Galter D, Riess O, Biskup S, Milnerwood AJ, Stoessl AJ, Farrer MJ, Sossi V.

J Parkinsons Dis. 2014;4(3):483-98. doi: 10.3233/JPD-140344.

PMID:
25000966
15.

Comparison of three hypothermic target temperatures for the treatment of hypoxic ischemia: mRNA level responses of eight genes in the piglet brain.

Olson L, Faulkner S, Lundströmer K, Kerenyi A, Kelen D, Chandrasekaran M, Ådén U, Olson L, Golay X, Lagercrantz H, Robertson NJ, Galter D.

Transl Stroke Res. 2013 Apr;4(2):248-57. doi: 10.1007/s12975-012-0215-4. Epub 2012 Oct 14.

PMID:
24323276
16.

Modulation of the endoplasmic reticulum-mitochondria interface in Alzheimer's disease and related models.

Hedskog L, Pinho CM, Filadi R, Rönnbäck A, Hertwig L, Wiehager B, Larssen P, Gellhaar S, Sandebring A, Westerlund M, Graff C, Winblad B, Galter D, Behbahani H, Pizzo P, Glaser E, Ankarcrona M.

Proc Natl Acad Sci U S A. 2013 May 7;110(19):7916-21. doi: 10.1073/pnas.1300677110. Epub 2013 Apr 25.

17.

mRNA expression, splicing and editing in the embryonic and adult mouse cerebral cortex.

Dillman AA, Hauser DN, Gibbs JR, Nalls MA, McCoy MK, Rudenko IN, Galter D, Cookson MR.

Nat Neurosci. 2013 Apr;16(4):499-506. doi: 10.1038/nn.3332. Epub 2013 Feb 17.

18.

Enhanced dendritogenesis and axogenesis in hippocampal neuroblasts of LRRK2 knockout mice.

Paus M, Kohl Z, Ben Abdallah NM, Galter D, Gillardon F, Winkler J.

Brain Res. 2013 Feb 25;1497:85-100. doi: 10.1016/j.brainres.2012.12.024. Epub 2012 Dec 25.

PMID:
23270607
19.

Large-scale replication and heterogeneity in Parkinson disease genetic loci.

Sharma M, Ioannidis JP, Aasly JO, Annesi G, Brice A, Van Broeckhoven C, Bertram L, Bozi M, Crosiers D, Clarke C, Facheris M, Farrer M, Garraux G, Gispert S, Auburger G, Vilariño-Güell C, Hadjigeorgiou GM, Hicks AA, Hattori N, Jeon B, Lesage S, Lill CM, Lin JJ, Lynch T, Lichtner P, Lang AE, Mok V, Jasinska-Myga B, Mellick GD, Morrison KE, Opala G, Pramstaller PP, Pichler I, Park SS, Quattrone A, Rogaeva E, Ross OA, Stefanis L, Stockton JD, Satake W, Silburn PA, Theuns J, Tan EK, Toda T, Tomiyama H, Uitti RJ, Wirdefeldt K, Wszolek Z, Xiromerisiou G, Yueh KC, Zhao Y, Gasser T, Maraganore D, Krüger R; GEO-PD Consortium.

Neurology. 2012 Aug 14;79(7):659-67. doi: 10.1212/WNL.0b013e318264e353. Epub 2012 Jul 11.

20.

Association of a protective paraoxonase 1 (PON1) polymorphism in Parkinson's disease.

Belin AC, Ran C, Anvret A, Paddock S, Westerlund M, Håkansson A, Nissbrandt H, Söderkvist P, Dizdar N, Ahmadi A, Anvret M, Willows T, Sydow O, Galter D.

Neurosci Lett. 2012 Jul 26;522(1):30-5. doi: 10.1016/j.neulet.2012.06.007. Epub 2012 Jun 13.

PMID:
22704918

Supplemental Content

Loading ...
Support Center